Botulinum Toxin Injection With Prostate Brachytherapy

Withdrawn before enrolling · Phase 2

Conditions studied: Prostate Cancer, Lower Urinary Tract Symptoms, Radioactive Seed Implantation

In brief

The purpose of this study is to see if botox injection into the prostate during seed implantation (brachytherapy) for prostate cancer a) improves urinary symptoms or avoids need for urinary tract instrumentation over the 6-8 month post-operative period when one wants to avoid manipulating the radioactive seeds, and b) speeds up the drop in PSA. Patients will be randomized to botox vs saline injection, at the completion of the seed implantation procedure.

Key facts

Study ID

NCT00681148

Run by

Emory University

People needed

0

Expected to finish

2012-07-01

Last updated by the study team

2013-11-21

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy proven prostate cancer undergoing brachytherapy

You may not qualify if…

• Prior allergic reaction to botulinum toxin

Where it is running

• Emory Clinic, Emory University Hospital — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.